Search for: "WYETH PHARMACEUTICALS COMPANY" Results 521 - 540 of 547
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Sep 2007, 1:00 am
HRT Patient's Personal Injury Claim Found to Be Time-Barred The Legal Intelligencer A woman who sued Wyeth Pharmaceuticals, claiming that the hormone replacement therapy she took was the cause of her breast cancer, is barred by the two-year statute of limitations from bringing a personal injury claim, a Philadelphia Common Pleas judge ruled Monday. [read post]
13 Sep 2007, 10:48 am
"Well, here goes.Anybody who currently defends FDA-regulated manufacturers in product liability actions knows two things: (1) over the past few years, plaintiffs have "discovered" consumer fraud statutes - raising them from the "miscellaneous" status they'd previously held to something that's routinely pleaded and pursued; and (2) New Jersey has become a relative hotbed of consumer protection litigation because the New Jersey statute is one of the most liberal… [read post]
7 Sep 2007, 3:03 am
District Court rejected Wyeth's request for an injunction that would have kept Teva from selling its version of the heartburn drug until a patent dispute between the companies was resolved.Teva and partner Sun Pharmaceuticals had promised not to sell the drug before Friday. [read post]
20 Aug 2007, 11:41 am
Here are some of the discussions taking place today: Is buying Wyeth a good move for the pharmaceutical company Pfizer? [read post]
23 Jul 2007, 6:58 am
It was what attorney Robert Brava-Partain, the ubiquitous suer of pharmaceutical companies, had to say. [read post]
9 Jul 2007, 9:04 pm
Zobel found that a patent on an invention licensed by Ariad Pharmaceuticals in 1991 was valid and enforceable, and that a jury's finding, in 2006, that Eli Lilly and Company had infringed the patent would stand. [read post]
6 Jul 2007, 4:29 am
Wyeth Laboratories, Inc., 533 N.E.2d 748, 755 (Ohio 1988). [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
4 Jun 2007, 12:56 am
Wyeth means that the first hormone therapy case to reach trial in the city's Complex Litigation Center has effectively ended with a Wyeth victory despite a sizable jury award in favor of the plaintiffs. [read post]
31 May 2007, 6:11 am
Wyeth Lawsuit (Posted by Tom Lamb at DrugInjuryWatch.com) On May 31, 2007 Wyeth announced that the Philadelphia Court of Common Pleas, of the Pennsylvania state court system, had granted the pharmaceutical company's motion for post-trial relief, and entered a judgment notwithstanding the verdict in favor of Wyeth in the lawsuit Jennie Nelson v. [read post]
26 May 2007, 11:26 pm
Johnson & Johnson, based in New Brunswick, was granted a federal court injunction two months ago blocking Mylan from selling copycat versions until the patent expires in 2008.# Wyeth's Effexor XR, which rang up $3.5 billion in 2006 sales, is being challenged by Alza, a J&J company. [read post]
21 May 2007, 8:03 am
The appeal by the pharmaceutical company, Wyeth, involves a challenge to a separate labeling requirement imposed by the state of Vermont on Wyeth's anti-nausea drug, Phenergan. [read post]
27 Apr 2007, 12:04 pm
Amgen persuasively explained the position of his company in a scenario that is echoed by all major pioneer pharma and biotech entities and manifests the futility of any attempt to ram through Congress a one-size-fits-all "second" window solution. [read post]
16 Apr 2007, 3:04 am
Defendant pharmaceutical company Wyeth's appeal of the judgment was noteworthy because it would have tested Texas' statutory cap limiting punitive damages. [read post]
15 Apr 2007, 2:42 am
Further to discussion about Ariad's US patent 6,410,516, the AP reported on April 13:Ariad Pharmaceuticals Inc. said late Friday [April 13] it filed a counter claim against Amgen Inc. over the patent to methods of treating human disease by regulating NF-(kappa)B cell-signaling activity.The claim _ which is also against drug maker Wyeth _ is a response to a lawsuit filed by Amgen against Ariad, saying the company's claims to the patent are invalid and Amgen has… [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]